| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Prime Medicine, Inc. | Director | Stock Option (right to buy) | 45,000 | 01 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | 01 Aug 2025 | 6 | $0 | 4 | Director | 05 Aug 2025, 20:43 |
| PRME | Prime Medicine, Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 18:13 |
| PRME | Prime Medicine, Inc. | 19 May 2025 | 1 | $0 | 4 | Director | 19 May 2025, 19:45 |
| PRME | Prime Medicine, Inc. | 12 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:59 |
| PRME | Prime Medicine, Inc. | 29 Feb 2024 | 1 | $0 | 4 | Director | 04 Mar 2024, 21:20 |
| PRME | Prime Medicine, Inc. | 10 May 2023 | 1 | $0 | 4 | Director | 12 May 2023, 16:30 |
| PRME | Prime Medicine, Inc. | 10 May 2023 | 0 | $0 | 3 | Director | 12 May 2023, 16:26 |